Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Finance Watch: VC Deals Keep Up Fast Pace With $1.1bn In Less Than Three Weeks

Executive Summary

Finance Watch has noted $1.1bn worth of venture capital deals so far in 2019. Meanwhile, public offerings continue to be muted by the US government shutdown, though Revance and others sold shares. Also, Five Prime and others reveal layoffs and strategic shifts.

Advertisement

Related Content

Keeping Track Of The US FDA's Final Approvals Of 2018
Finance Watch: Alternative Funding Sources Crucial Even Amidst A Biopharma VC Boom
Asia Deal Watch: ReVance Licenses Chinese Rights To Botox Competitor To Fosun
Galecto Funnels Funding Into Phase II For Inhaled IPF Therapy
Pipeline Watch: Phase III Starts With Murepavadin, Infigratinib And Mavacamten
Finance Watch: VC Tally Hits $14.5bn For 2018, Beating 2017 With A Quarter Left To Go
Finance Watch: Vaccinex, Aridis Launch August's First US IPOs As The Summer Simmer Slows
Finance Watch: Pfizer Ventures' Dalton Makes Sense Of Neuroscience Focus Within New $600m VC Fund Commitment
Revance's Long-Acting RT002 Will Have Slow-Moving Impact On Allergan
Merck thinks climate is right to repatriate cash

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC124509

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel